Up‐and‐down procedure (UDP) determinations of acute oral toxicity of nitroso degradation products of hexahydro‐1,3,5‐trinitro‐1,3,5‐triazine (RDX)
- 9 August 2005
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 25 (5) , 427-434
Abstract
Hexahydro‐1,3,5‐trinitro‐1,3,5‐triazine (RDX), a widely used military explosive and soil and ground water contaminant of munitions manufacturing and artillery training sites, undergoes microbial nitroreductase metabolism to hexahydro‐1‐nitroso‐3,5‐dinitro‐1,3,5‐triazine (MNX), hexahydro‐1,3‐dinitroso‐5‐nitro‐1,3,5‐triazine (DNX), and hexahydro‐1,3,5‐trinitroso‐1,3,5‐triazine (TNX). Human occupational and accidental exposures to RDX, as well as acute oral exposures in rats, result in seizures, but little is known about the toxicity of the RDX degradation products. The main objective of the present study was to determine the oral LD50 of the most potent RDX N‐nitroso product in female Sprague‐Dawley rats using the recently validated up‐and‐down procedure (UDP). With only 26 rats, MNX was identified as the most potent metabolite and a maximum likelihood estimate of 187 mg kg−1 (95% confidence interval 118–491 mg kg−1) for its LD50 was established and found equivalent to that of RDX determined with the same protocol. CNS toxicity, manifested as forelimb clonic seizures progressing to generalized clonic‐tonic seizures, was the critical adverse effect. Further, confirmation of the UDP LD50 for MNX with a fixed‐dose design enabled identification of 94 mg kg−1 as the highest nonlethal dose. An ED50 of 57 mg kg−1 was determined for neurotoxicity, while splenic hemosiderosis and decreased blood hematocrit and hemoglobin concentration occurred with a threshold at 94 mg kg−1 in 14‐day survivors. These studies, while providing new toxicity data necessary for the management of RDX‐contaminated sites, illustrate the efficiency of the UDP for comparative acute toxicity determinations and its value in guiding further characterization of dose dependency of identified adverse effects. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Biotransformation of Hexahydro-1,3,5-Trinitro-1,3,5-Triazine (RDX) by a Rabbit Liver Cytochrome P450: Insight into the Mechanism of RDX Biodegradation by Rhodococcus sp. Strain DN22Applied and Environmental Microbiology, 2003
- Accidental Oral Poisoning Caused by Rdx (Cyclonite): A Report of 5 CasesJournal of Intensive Care Medicine, 2003
- Pharmacokinetics of Sodium Nitrite-Induced Methemoglobinemia in the RatDrug Metabolism and Disposition, 2002
- Use of Liquid Chromatography/Tandem Mass Spectrometry To Detect Distinctive Indicators of In Situ RDX Transformation in Contaminated GroundwaterEnvironmental Science & Technology, 2002
- Use of a Salmonella microsuspension bioassay to detect the mutagenicity of munitions compounds at low concentrationsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2001
- Characterization of Metabolites during Biodegradation of Hexahydro-1,3,5-Trinitro-1,3,5-Triazine (RDX) with Municipal Anaerobic SludgeApplied and Environmental Microbiology, 2000
- Seizures Caused by Ingestion of Composition C-4Annals of Emergency Medicine, 1995
- Antineutrophil Cytoplasmic Antibody Associated With Pulmonary HemorrhageSouthern Medical Journal, 1992
- Convulsant properties of cyclotrimethylenetrinitramine (RDX): Spontaneous, audiogenic, and amygdaloid kindled seizure activity*1Toxicology and Applied Pharmacology, 1988
- Mammalian Toxicological Evaluation of RDX1980